Single-use Bioprocessing Market Size Worth $9,342 Million By Key Players : Thermo Fisher Scientific, Danaher Corporation, GE Healthcare, Sartorius Stedim Biotech S.A and Others

The Global Single-use Bioprocessing (Sub) Market was valued at $2,800 million in 2016, and is expected to reach $9,342 million by 2023, registering a CAGR of 18.7% from 2017 to 2023. Single-use bioprocessing employs disposable technologies for the development and manufacturing of pharmaceutical products such as vaccines, monoclonal antibodies (mAbs), personalized medicine, and others. The adoption of single-use bioprocessing products has witnessed significant increased during the developmental stages of drugs and manufacturing of several biopharmaceuticals.

This product has revolutionized the upstream as well as downstream processes of manufacturing drugs making it faster, simpler, and cheaper. Factors that boost the growth of single-use bioprocessing market include increase in demand for biopharmaceuticals, rise in adoption of disposable technologies, low risk of product cross-contamination attributed to SUB technologies, and less floor space requirement. However, certain aspects such as, extractability and leachability issues and stringent regulations pertaining to use of disposable systems in biopharmaceutical industry hamper the market growth.

The report provides a comprehensive analysis of the key players operating in the global single-use bioprocessing market such as Thermo Fisher Scientific, Danaher Corporation, GE Healthcare (General Electric Company), Sartorius Stedim Biotech S.A, Merck Millipore (Merck Group), 3M Company, Eppendorf AG, Finesse Solutions, Inc., Applikon Biotechnology B.V., and Cesco Bioengineering Co., Ltd.

The other key players in the value chain include Octane Biotech Inc., PBS Biotech, Inc., Meissner Filtration Products, Inc., Sentinel Process Systems Inc., CMC Biologics (Asahi Glass Co.), Novasep, PendoTECH, and BioPure Technology Ltd.

Get Sample PDF Brochure : https://www.alliedmarketresearch.com/request-sample/2359

Segment Review

The single-use bioprocessing market is segmented based on product, method, application, end user, and region. Based on product, it is classified into bioreactors, tangential-flow filtration devices, depth filters, disposable filter cartridges, media bags & containers, mixing systems, tubing assemblies, sampling systems, and others. Based on application, it is divided into monoclonal antibody production, vaccine production, plant cell cultivation, patient specific cell therapies, and others. On the basis of method, it is categorized into filtration, storage, cell culture, mixing, and purification. Based on end user, it is classified into biopharmaceutical manufacturers, life science R&D companies & academic research institutes, and contract research organizations & manufacturers.

The media bags & containers segment dominated the global single-use bioprocessing market in 2016, and is anticipated maintain this trend throughout the forecast period. This is attributed to the fact that single-use bioprocessing media bags & containers are used in various bioprocessing processes. In addition, single-use containers are widely used for critical liquid handling applications in the biomanufacturing and biopharmaceutical industries. Moreover, single-use bioprocessing technologies are used in the production of monoclonal antibodies (mAb); hence, this segment has a leading share in the global single-use bioprocessing market.

Drivers, Restraints, and Opportunities

The impact of the driving factors is expected to overshadow that of the restraints. Moreover, increase in focus toward mergers, acquisitions, and product launches offer lucrative opportunities for the expansion of the global single-use bioprocessing market.

Do Purchase Enquiry at : https://www.alliedmarketresearch.com/purchase-enquiry/2359

Key Benefits

• The study provides an in-depth analysis along with the current trends and future estimations of the global single-use bioprocessing market to elucidate the imminent investment pockets.
• Comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
• The quantitative analysis of the industry for the period of 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of key segments of the industry is provided to understand the type of products and indications used across the globe.
• Key market players and their strategies are analyzed to understand the competitive outlook of the market.

About us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David C
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.